The global meningococcal vaccine market is set to experience remarkable growth, with its valuation expected to rise from USD 3.95 billion in 2024 to an impressive USD 9.01 billion by 2034, reflecting a robust CAGR of 8.6% during the forecast period, according to industry analysis. The surge in market growth is largely attributed to the …